桑菊饮合清金汤加减治疗病毒性肺炎急性加重期的效果观察
Observation on the Effect of Combining Sangju Drink and Qingjin Tang Plus Reduction in the Treatment of Acute Exacerbation of Viral Pneumonia
DOI: 10.12677/TCM.2023.129389, PDF,   
作者: 赵 萍:湖北中医药大学第一临床学院,湖北 武汉
关键词: 病毒性肺炎急性加重桑菊饮清金汤Viral Pneumonia Acute Exacerbation Sangju Drink Qingjin Tang
摘要: 目的:主要通过观察桑菊饮合清金汤加减合用,验证其在治疗病毒性肺炎急性加重期的临床效果。方法:按照研究要求随机将82例病毒性肺炎患者分为两组,其中对照组(41例)采用常规西药治疗,观察组(41例)在此基础上加用桑菊饮合清金汤随证加减,观察并记录两组患者的临床疗效,评估治疗后较治疗前实验室检查指标(WBC、LYMPHN、NEUT、MONON、ESR、CRP、PCT等),影像学显示(肺部CT)的改变程度。结果:观察组、对照组的有效率分别是95.11%和80.78%,且前者有效率明显高于后者(P < 0.05)。经一个疗程的治疗后,观察组、对照组的肺部CT及实验室检查结果都取得一定程度的改善,其中前者的改善效果相于后者更显著(P < 0.05)。结论:桑菊饮合清金汤加减治疗法在临床上面可以明显看出对病毒性肺炎急性加重病症的治疗成效,很大程度上改善治疗有效率,其临床疗效确切,具有推广价值。
Abstract: Objective: To verify the clinical effect of Sangju Drink combined with Qingjin Tang in the treatment of acute exacerbation of viral pneumonia by observing the combination of Sangju Drink and Qingjin Tang plus and minus. Methods: In accordance with the requirements of the study, 82 patients with viral pneumonia were randomly divided into two groups, in which the control group (41 cases) was treated with conventional western medicines, and the observation group (41 cases) was treated with the addition of Sangju Drink and Qingjin Tang with additional subtractions according to the evidence, and the control group (41 cases) was treated with conventional western medicines. Observe and record the clinical efficacy of the two groups of patients, and assess the indicators of laboratory tests after treatment compared with those before treatment (WBC, LYMPHN, NEUT, MONON, ESR, CRP, PCT, etc.), the degree of change shown on imaging (CT of the lungs). Results: The effective rates of the observation group and the control group were 95.11% and 80.78%, respectively, and the effective rate of the former was significantly higher than that of the latter (P < 0.05). After one course of treatment, the CT and laboratory findings of the lungs of the observation group and the control group improved to a certain extent, with the improvement of the former group being more significant than that of the latter group (P < 0.05). Conclusion: The treatment of acute exacerbation of viral pneumonia with the addition and subtraction of Sangju Drink and Qingjin Tang can be clearly seen in the clinic, which can improve the treatment efficiency to a large extent, and its clinical efficacy is exact and has the value of popularization.
文章引用:赵萍. 桑菊饮合清金汤加减治疗病毒性肺炎急性加重期的效果观察[J]. 中医学, 2023, 12(9): 2596-2601. https://doi.org/10.12677/TCM.2023.129389

参考文献

[1] 黄家望, 马心悦, 朱梦晨, 等. 基于“扶正祛邪”治则的中医药抗病毒性肺炎作用机制的研究进展[J]. 中医药学报, 2022, 50(12): 97-101. [Google Scholar] [CrossRef
[2] Ruuskanen, O., Lahti, E., Jennings, L.C. and Murdoch, D.R. (2011) Viral Pneumonia. The Lancet, 377, 1264-1275. [Google Scholar] [CrossRef
[3] Dandachi, D. and Rodriguez-Barradas, M.C. (2018) Viral Pneumonia: Etiologies and Treatment. Journal of Investigative Medicine, 66, 957-965. [Google Scholar] [CrossRef] [PubMed]
[4] 刘音, 杨竞铖, 贺小旭, 等. 95例重症病毒性肺炎患者的临床特征及预后影响因素分析[J]. 临床肺科杂志, 2022, 27(10): 1463-1467.
[5] Amarelle, L., Lecuona, E. and Sznajder, J.I. (2017) Tratamiento antigripal: Fármacos actualmente utilizados y nuevos agentes en desarrollo [Anti-Influenza Treatment: Drugs Currently Used and under Development]. Archivos de Bronconeumología, 53, 19-26. [Google Scholar] [CrossRef] [PubMed]
[6] 孙天峰, 吴静文, 高倩. 清肺排毒汤对病毒性肺炎患者主要症状消失时间、血清D-二聚体水平及ESR的影响[J]. 沈阳药科大学学报, 2021, 38(S2): 70-71.
[7] Koo, H.J., Lim, S., Choe, J., Choi, S.H., Sung, H. and Do, K.H. (2018) Radiographic and CT Features of Viral Pneumonia. RadioGraphics, 38, 719-739. [Google Scholar] [CrossRef] [PubMed]
[8] Jin, W., Dong, S., Dong, C. and Ye, X. (2021) Hybrid Ensemble Model for Differential Diagnosis between COVID-19 and Common Viral Pneumonia by Chest X-Ray Radiograph. Computers in Biology and Medicine, 131, Article ID: 104252. [Google Scholar] [CrossRef] [PubMed]
[9] Li, Q., Wang, J., Zhou, X., Lu, H., Lu, M. and Huang, L. (2021) Case Report: Viral Pneumonia Could Prompt the Advancement of Immune-Mediated Liver Disease. Frontiers in Medicine, 8, Article 582620. [Google Scholar] [CrossRef] [PubMed]
[10] 张永芳, 张鸿雁. 干扰素雾化吸入辅助治疗对新生儿病毒性肺炎病程中炎症及应激反应的影响[J]. 海南医学院学报, 2018, 24(12): 1175-1178. [Google Scholar] [CrossRef
[11] 曹季平. 基于《社区获得性肺炎诊断和治疗指南(2016版)》对医院成人CAP患者抗菌药物使用的相关因素分析[J]. 抗感染药学, 2020, 17(3): 323-327. [Google Scholar] [CrossRef
[12] Gross, A.E., Van Schooneveld, T.C., Olsen, K.M., et al. (2014) Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia. Antimicrobial Agents and Chemotherapy, 58, 5262-5268. [Google Scholar] [CrossRef
[13] Andruska, A., Micek, S.T., Shindo, Y., et al. (2015) Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission. Chest, 148, 103-111. [Google Scholar] [CrossRef] [PubMed]
[14] 古丽达娜∙安那斯汗, 刘静. 探讨中医对肺炎的辨证治疗的功效[J]. 临床医药文献电子杂志, 2016, 3(24): 4757, 4759. [Google Scholar] [CrossRef
[15] 李瑞, 孙国同, 黄贝, 等. 达原饮抗病毒性肺炎研究进展[J]. 中药药理与临床, 2023, 39(6): 117-121. [Google Scholar] [CrossRef
[16] Ren, J.L., Zhang, A.H. and Wang, X.J. (2020) Traditional Chinese Medicine for COVID-19 Treatment. Pharmacological Research, 155, Article ID: 104743. [Google Scholar] [CrossRef] [PubMed]
[17] 艾军, 汪受传, 戴铭, 等. 中医药治疗病毒性肺炎热与痰证候关联动态疗效评价[J]. 世界中医药, 2016, 11(9): 1667-1669.
[18] 张福明, 石垚, 韩园园, 等. 鱼腥草治疗病毒性肺炎作用机制的“成分-靶点-通路”多层次互作网络研究[J]. 药物评价研究, 2022, 45(11): 2188-2199.